Sign in

CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943134940
Phone
4154825300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale President & CEO sold 11,495 shares at $22.37 ($257,143)
  2. 4 Open-market sale SVP & Chief Commercial Officer sold 15,358 shares at $22.37 ($343,558)
  3. 4 Open-market sale SVP, COO & CFO sold 7,977 shares at $22.37 ($178,445)
  4. 8-K Event Material agreement
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 4 Open-market sale SVP & General Counsel sold 5,344 shares at $19.45 ($103,941)
  10. 4 Open-market sale President & CEO sold 450,000 shares at an average $19.93 ($8,966,931)
  11. 4 Open-market sale SVP, COO & CFO sold 150,000 shares at an average $19.86 ($2,979,629)
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 4 Open-market sale SVP & Chief Accounting Officer sold 75,000 shares at $18.62 ($1,396,500)
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 8-K Event Results of operations · Regulation FD disclosure
  16. 8-K Event Acquisition or sale completed
  17. 4 Option exercise Director acquired 40,000 shares (option exercise)
  18. 4 Gift Director gave 51,500 shares (gift)
  19. 4 Grant or award Chief R&D Officer acquired 40,000 shares (grant or award)
  20. 4 Grant or award SVP & General Counsel acquired 28,550 shares (grant or award)

Page 23 of 100 · 1,982 filings